UBS Group’s Xponential Fitness XPOF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-178,000
Closed -$1.46M 11255
2025
Q4
$1.46M Sell
178,000
-39,500
-18% -$281K ﹤0.01% 5240
2025
Q3
$1.69M Sell
217,500
-195,000
-47% -$1.78M ﹤0.01% 5116
2025
Q2
$3.09M Hold
412,500
﹤0.01% 4362
2025
Q1
$3.44M Buy
+412,500
New +$5.75M ﹤0.01% 4180
2023
Q3
Sell
-343,500
Closed -$5.93M 10030
2023
Q2
$5.93M Buy
343,500
+32,500
+10% +$920K ﹤0.01% 2418
2023
Q1
$9.45M Sell
311,000
-173,400
-36% -$4.59M ﹤0.01% 1934
2022
Q4
$11.1M Buy
484,400
+40,600
+9% +$837K ﹤0.01% 1845
2022
Q3
$8.1M Buy
+443,800
New +$7.47M ﹤0.01% 1965

Other funds holding XPOF

UBS Group's XPOF Position: Q1 2026 in Review

UBS Group reduced its Xponential Fitness (XPOF) stake by 54% in Q1 2026, selling an estimated $582K and leaving 68,608 shares worth $413K. The position accounts for ﹤0.01% of the portfolio, ranked #6212.

UBS Group first reported a position in XPOF in Q3 2021 and has held it in 19 quarters since. The position peaked at $2.43M in Q1 2025. 113 funds tracked by Wall St. Rank hold XPOF as of Q1 2026.

  • UBS Group held 68,608 shares of Xponential Fitness worth $413K as of Q1 2026.
  • UBS Group sold 80,565 Xponential Fitness shares in Q1 2026, an estimated $582K.
  • Xponential Fitness made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #6212 holding.
  • UBS Group first reported a position in Xponential Fitness in Q3 2021 and has held it in 19 quarters since.
  • UBS Group's Xponential Fitness position peaked at $2.43M in Q1 2025.
  • 113 funds tracked by Wall St. Rank held Xponential Fitness as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.